CLINICAL_TRIALS
ClinicalTrials.gov record update
Randomized Open-label 2-arm Parallel Design Comparator Study of the Effect of Adalat® XL® Compared to Diltiazem on Proteinuria and Blood Pressure in Patients With Diabetes and Mild to Moderate Hypertension When Used as an Add on to Avalide®
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00713011
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:35:24.979248+00:00
- Published At
- 2012-11-16T00:00:00+00:00
- Record Updated At
- 2012-11-16
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Diabetic Nephropathies", "Hypertension"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2012-11-16"- protocolSection.identificationModule.nctId
"NCT00713011"- protocolSection.identificationModule.officialTitle
"Randomized Open-label 2-arm Parallel Design Comparator Study of the Effect of Adalat\u00ae XL\u00ae Compared to Diltiazem on Proteinuria and Blood Pressure in Patients With Diabetes and Mild to Moderate Hypertension When Used as an Add on to Avalide\u00ae"- protocolSection.statusModule.overallStatus
"WITHDRAWN"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.